TG Therapeutics, Inc. Soared
Thu, Nov 10, 2022 at 07:57 PM
TG Therapeutics, Inc. (TGTX:NASDAQ) soared at $8.43, representing a gain of 63.4%. On Thu, Nov 10, 2022, TGTX:NASDAQ touched a New 2-Week High of $8.43. The stock got featured on our News Catalysts scanner on Thu, Nov 10, 2022 at 07:45 AM in the 'INVESTOR UPDATE' category. From Thu, Oct 27, 2022, the stock recorded 40.00% Up Days and 36.36% Green Days
About TG Therapeutics, Inc. (TGTX:NASDAQ)
TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development & commercialization of novel treatments for B-cell malignancies and autoimmune diseases.
Top 10 Gainers:
- Fast Radius Inc. (FSRD:NASDAQ), 156.19%
- SHF Holdings Inc Cl A (SHFS:NASDAQ), 86.7%
- Elite Education Group International Ltd. (EEIQ:NASDAQ), 72.12%
- Magnite Inc. (MGNI:NASDAQ), 65.57%
- TG Therapeutics, Inc. (TGTX:NASDAQ), 63.37%
- Digital Turbine, Inc. (APPS:NASDAQ), 60.91%
- Repay Holdings Corporation (RPAY:NASDAQ), 50.68%
- Bull Horn Holdings Corp. (BHSE:NASDAQ), 44.67%
- BioLife Solutions, Inc. (BLFS:NASDAQ), 42.77%
- Ebix, Inc. (EBIX:NASDAQ), 42.11%